Endo International plc (NASDAQ:ENDP) [Trend Analysis] surged reacts as active mover, shares a gain 0.08% to traded at $11.82 and the percentage gap between open changing to regular change was 0.01%. Endo International plc (NASDAQ:ENDP) declared that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug Application for ephedrine sulfate injection, a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings.
According to IMS Health data, U.S. sales of ephedrine sulfate injection products were approximately $177 million for the 12 months ended November 30, 2016.Ephedrine sulfate for injection is packaged in cartons of twenty-five 50mg/mL, 1mL single use vials. Par expects to start shipping the product in February 2017. The firm’s current ratio calculated as 0.80 for the most recent quarter.
The firm past twelve months price to sales ratio was 0.69 and price to cash ratio remained 4.69. As far as the returns are concern, the return on equity was recorded as -2.10% and return on investment was 0.90% while its return on asset stayed at -0.70%. The firm has total debt to equity ratio measured as 1.37.
Randgold Resources Limited (NASDAQ:GOLD) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 3.47% to close at $85.01 with the total traded volume of 212792 shares. Randgold Resources Limited (GOLD) reported that negotiations are underway to resolve an illegal sit-in which started at the company’s Tongon mine in Côte d’Ivoire late on January 26 by some employees demanding annual ex gratia payments.
The company said representatives of the central and local governments as well as the union, which does not support the sit-in, have joined management in engaging with the workers to end their action.Separately, Randgold said its Loulo-Gounkoto gold mining complex in Mali is expected to report another new production record for the fourth quarter of 2016, rounding off on a high note what has been a good year for the company’s flagship operation. The firm has institutional ownership of 40.50%, while insider ownership included 3.90%. Its price to sales ratio ended at 6.95. GOLD attains analyst recommendation of 2.10 with week performance of -4.30%.